Parameter
| Biomarker | LRRC59 | Full name | Leucine-Rich Repeat Containing 59 | Molecular Type | Protein & immune-infiltration modulator |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis & prognosis |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue (IHC, qRT-PCR, database analysis) | ||
| Pathobiological Mechanisms | Over-expressed in BC; associated with poor survival; hypomethylation indicates unfavorable prognosis; correlates with multiple immune-cell subsets; knock-down inhibits proliferation and migration | ||||
| Clinical Availability Status | Research verification stage: function validated in cells and tissues; clinical validation required | ||||
| Notes and Dynamics | Leucine-rich-repeat protein offering multi-dimensional value for diagnosis, prognosis and immunotherapy of BC | ||||